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Abstract
Diabetes mellitus is referred to as non-communicable epidemic of the 21st century and the fight against diabetes
is one of medical and social challenges. One of its complications is damage to periodontal tissues that is
accompanied by tooth loss. Any removable denture is a foreign body being a stress factor for the oral cavity.
The objective of the research was to study dynamic changes in the activity of stress factor indicators, namely
salivary cortisol, glucose and alpha-amylase levels in diabetic patients after prosthodontic treatment with complete
removable laminar dentures.
Materials and Methods. For this study, patients at the age of 45 to 74 years were divided into two groups:
Group I included 52 edentulous patients with type 2 diabetes mellitus who were treated with acrylic resin complete
removable laminar dentures; Group II comprised 52 edentulous patients without endocrine pathology who were
treated with acrylic resin complete removable laminar dentures as well. Saliva served as the study material. The
enzyme-linked immunosorbent assay was used to determine salivary cortisol levels. Glucose concentration in
saliva was determined by a unified enzymatic method. Alpha-amylase activity was determined by the enzymatic
colorimetric method.
Results. According to the research results, before prosthodontic treatment, salivary cortisol levels of patients
with diabetes mellitus were 2.4 times higher as compared to patients without somatic pathology. In phase I
of adaptation to complete removable laminar dentures, in patients with diabetes mellitus, salivary cortisol
concentration increased drastically by 1.4 times as compared to the indicator before prosthodontic treatment
(5.61 ± 0.83 ng/ml vs. 4.02 ± 0.65 ng/ml, p < 0.01), while in the group of patients without endocrine pathology,
cortisol levels increased by 1.2 times; salivary glucose level of patients with diabetes mellitus increased by 1.3
times, while in patients without endocrine pathology, it increased by 1.1 times; in patients of Group I, salivary
alpha-amylase levels increased by 1.2 times, while in patients of Group II, salivary alpha-amylase concentration
increased by 1.05 times.
Conclusions. In patients with diabetes mellitus, changes in saliva composition indicate a significant reduction in
the adaptation mechanisms, that complicates and significantly prolongs the period of adaptation to complete
removable laminar dentures.
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Problem statement and analysis of
the latest research
The endocrine system is the major component of
humoral regulation of bodily functions. Special-
ists in most fields of medicine have to deal with
manifestations of endocrine disorders [9].
Diabetes mellitus (DM) is referred to as non-
communicable epidemic of the 21st century and
the fight against DM is one of medical and so-
cial challenges. DM prevalence rises due to the
increasing number of people with genetic predis-
position to DM, the increase in an average life ex-
pectancy, the intensification of the pace of life, en-
vironmental degradation and social deterioration,
dietary changes that, in combination with physi-
cal inactivity, result in the increasing number of
obese people and increased incidence of chronic
cardiovascular diseases (hypertension, atherosclero-
sis) that are considered as risk factors as well. One
of diabetic complications is damage to periodontal
tissues that is accompanied by complete tooth loss
that requires prosthodontic treatment [1, 2, 7]. Any
type of dental prostheses, primarily removable one,
is a foreign body being a stress factor for the oral
cavity. Therefore, the term ”adaptation” is closely
associated with removable dentures [8]. Accord-
ing to literature, stress is a general non-specific
response of the body to stimuli that is characterized
by activating the neurohumoral mechanisms and
metabolic changes they caused. According to B.
Folkov, when defining the term ”stress”, standard
nature of a stress response and its significant role as
a necessary component of more complex adaptation
process should be emphasized [3]. The effects of
stress on the cardiovascular system, the gastroin-
testinal tract, and the central nervous system have
been well-studied; however, its effects on the oral
cavity during prosthodontic treatment of diabetic
edentulous patients with removable dentures at dif-
ferent stages of adaptation to complete removable
laminar dentures (CRLD) and the methods of pos-
sible correcting pathological changes in the oral
cavity have not been sufficiently studied yet. The
oral cavity, and especially the salivary glands, are
sensitive to stress due to their close correlation with
the neurohumoral mechanisms. Excessive or pro-
longed activation of the stress response, as well as
the lack of the adaptive responses to stress factors
may result in various pathological changes in tis-
sues and organs. The biological role of the stress
response is to adapt the body to unfavorable factors;
however, long-term effect of stress factors leads
to maladaptation, i.e., the impaired functions of
the physiological systems, structural changes that
result in organ diseases, including oral diseases.
The stress response is triggered by the activation
of the hypothalamic pituitary adrenal (HPA) axis
and the sympathoadrenal system that secrete the
corresponding hormones (adrenocorticotropic hor-
mone, ketosteroids and catecholamines). Changes
in the concentration of cortisol in saliva are used as
an indicator of the HPA axis activity; the reference
cortisol levels range from 0.2 to 4.4 ng/ml. In recent
years, salivary alpha-amylase (sAA) the secretion
of which is regulated by beta-adrenergic stimula-
tion has been suggested as a marker of emotional
stress. The reference value for sAA is 107 U/L.
Glucose level in saliva is considered as one of the
stress indicators as well; normal salivary glucose
levels are 0.2-0.3 mol/l [3, 6].
The objective of the research was to study dy-
namic changes in the indicators of stress factors in
saliva of diabetic patients during 3 phases of adap-
tation to CRLD.
1. Materials and Methods
For this study, patients at the age of 45 to 74 years
were divided into two groups: Group I included
52 edentulous patients with type 2 diabetes melli-
tus who were treated with acrylic resin complete
removable laminar dentures; Group II comprised
52 edentulous patients without endocrine pathology
who were treated with acrylic resin CRLD as well.
Saliva served as the study material: unstimulated
saliva samples were collected in volumetric tubes
by the spitting method for a period of 20 min in the
morning on an empty stomach. The studies were
carried out in all the 3 adaptation phases: on the 3rd,
7th and 28th days after denture placement.
The enzyme-linked immunosorbent
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assay (ELISA) was used to determine salivary cor-
tisol levels. Glucose concentration in saliva was
determined by a unified enzymatic method. AA ac-
tivity was determined by the enzymatic colorimetric
method [4].
For an objective assessment of the reliability
degree, the results obtained were statistically pro-
cessed using widely used methods of variation statis-
tics, the Pentium II PC, statistical software packages
Statgraphic 2.3 and Microsoft Excel 2000. The re-
sults obtained were statistically processed by calcu-
lating the arithmetic mean (M), the standard devi-
ation (σ ), the standard error (m). A t-test, where t
is a criterion of accuracy, M is the arithmetic mean,
Sx stands for sample standard deviation, was used
to determine if there was a significant difference
between the means of samples [5].
This study is a fragment of comprehensive re-
search of the Department of Dentistry of the Ed-
ucational and Research Institute of Postgraduate
Education ”Clinical and Experimental Substantia-
tion of New Methods for Diagnosis, Prevention and
Prosthodontic Treatment (of Dental Diseases) in
the Population of Ivano-Frankivsk Region (2017-
2020)”. No 0118u 003873.
2. Results
The results of the studies conducted are presented
in Table 1.
According to the results obtained, before
prosthodontic treatment of complete tooth loss, cor-
tisol concentration in saliva of patients with DM
was 4.02 ± 0.65 ng/ml, i.e., the upper reference
limit was observed. In patients without DM, before
prosthodontic treatment, the average cortisol level
was 1.66 ± 0.34 ng/ml being 2.4 times lower as
compared to patients with endocrine pathology.
In adaptation phase I, the phase of reflex stim-
ulation (on the 3rd day), salivary cortisol concen-
tration in patients of Group I increased drastically
by 1.4 times as compared to the indicator before
prosthodontic treatment (5.61 ± 0.83 ng/ml vs.
4.02 ± 0.65 ng/ml, p < 0.01). On the 7th day of
adaptation, the phase of conditioned reflex inhibi-
tion, patients with DM presented with a moderate in-
crease in salivary cortisol levels up to
6.15 ± 1.12 ng/ml, that was 1.5 times higher than
the initial values, p < 0.01. On the 28th day after
denture placement, the phase of extinction of condi-
tioned reflex stimuli, cortisol concentration in saliva
of patients with DM increased to 6.68± 1.21 ng/ml,
that was 1.08 times higher than the indicator ob-
tained on the 7th day, 1.7 times higher than the
indicator before obtained prosthodontic treatment
and exceeded the upper reference limit by 1.5 times,
p < 0.01.
In the group of patients without DM, there was
observed a more moderate increase in salivary cor-
tisol level in all the phases of adaptation to CRLD.
On the 3rd day after denture placement, cortisol
levels increased significantly by 1.2 times from
1.66 ± 0.34 ng/ml to 2.02 ± 0.42 ng/ml, p < 0.01.
On the 7th day, they increased to 2.33 ± 0.51 ng/ml,
p < 0.01. On the 28th day after CRLD place-
ment, salivary concentration of cortisol in patients
of Group II was 2.42 ± 0.63 ng/ml, that was
1.4 times higher than the initial data; however, it
did not exceed the reference range for this stress
factor. It is worth mentioning that in patients with-
out endocrine pathology, during all the adaptation
phases, there were observed significantly lower sali-
vary cortisol levels as compared to patients with
DM (Fig. 1).
Before prosthodontic treatment of complete tooth
loss with CRLD, salivary glucose level of patients
with DM was 0.44 ± 0.05 mol/l exceeding the nor-
mal range and that of patients without comorbid-
ity (0.23 ± 0.02 mol/l) by 1.5 and 1.9 times, re-
spectively, p < 0.01. In adaptation phase I, on the
3rd day, salivary glucose level of patients with DM
increased significantly by 1.3 times to
0.56 ± 0.07mol/l, p < 0.01. On the 7th day, this
indicator was 0.65 ± 0.08 mol/l, that was 1.5 times
higher than the initial values, p < 0.01. On the
28th day after CRLD placement, in patients of
Group I, the highest glucose concentration in saliva
was observed – 0.69± 0.09 mol/l, that was 1.6 times
higher than the indicator obtained before prosthodon-
tic treatment, p < 0.01.
In the group of patients without endocrine pathol-
ogy, in adaptation phase I, the increase in sali-
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Table 1. Indicators of stress factor activity in saliva of patients depending on the period of adaptation to
CRLD.
Group Adaptation phase
Indicators of stress factors
Cortisol (ng/ml) Glucose (mol/l) AA (U/L)
Group I (n=52)
Before prosthodontic treatment 4.02 ± 0.65* 0.44 ± 0.05* 96.42 ± 7.26*º
On the 3rd day 5.61 ± 0.83*º 0.56 ± 0.07*º 114.28 ± 8.63*º
On the 7th day 6.15 ± 1.12*º 0.65 ± 0.08*º 126.15 ± 9.55*º
On the 28th day 6.68 ± 1.21*º 0.69 ± 0.09*º 133.38 ± 9.93*º
Group II (n=52)
Before prosthodontic treatment 1.66 ± 0.34*º 0.23 ± 0.02*º 105.23 ± 8.44*º
On the 3rd day 2.02 ± 0.42*º 0.26 ± 0.03*º 110.61 ± 9.13*º
On the 7th day 2.33 ± 0.51*º 0.31 ± 0.04*º 116.39 ± 9.35*º
On the 28th day 2.42 ± 0.63*º 0.29 ± 0.04*º 112.52 ± 9.54*º
Notes:
* – a significant difference between the indicators of Group I and Group II, p<0.01;
º – a significant difference between the indicators before prosthodontic treatment, p<0.01.
Figure 1. Dynamic changes in salivary cortisol levels of all the patients.
vary glucose level by 1.1 times from 0.23 ± 0.02
mol/l to 0.26 ± 0.03 mol/l was observed as well,
p < 0.01. In adaptation phase II, there was ob-
served a moderate increase in salivary glucose level
(0.31 ± 0.04 mol/l). However, on the 28th day, in
the final adaptation phase, in patients of Group II,
the concentration of glucose in saliva decreased to
0.29 ± 0.04 mol/l, (p < 0.01) in contrast to patients
of Group I, whose glucose levels in saliva continued
to increase (Fig. 2).
Dynamic changes in amylolytic activity of all
the patients during various adaptation phases are
presented in Fig. 3. It is worth mentioning that in pa-
tients with DM, before prosthodontic treatment, the
level of sAA was 96.42 ± 7.26 U/L being 1.1 times
lower than normal values, while in patients without
endocrine pathology, sAA levels were within nor-
mal limits (105.23 ± 8.44 U/L) being 1.09 times
higher as compared to patients with DM.
In patients with DM, on the 3rd day of remov-
able denture placement, sAA levels increased by
1.2 times to 114.28 ± 8.63 U/L, p < 0.01. On the
7th day, in adaptation phase II, sAA concentration
increased by 1.3 times as compared to the initial val-
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Figure 2. Dynamic changes in salivary glucose levels of all the patients.
Figure 3. Dynamic changes in sAA levels of all the patients.
ues. On the 28th day, the level of amylolytic activity
increased by 1.4 times to 133.38 ± 9.93 U/L that
might indicate the stress response of the salivary
glands to removable dentures in diabetic patients.
In patients of Group II, amylolytic activity in-
creased as well; however, slowly increasing activity
was observed. In adaptation phase I, sAA concentra-
tion increased by 1.05 times from 105.23± 8.44 U/L
to 110.61 ± 9.13 U/L, p < 0.01.
In adaptation phase II, this indicator increased
to 116.39 ± 9.35 U/L, p < 0.01. In adaptation
phase III, sAA levels of patients without endocrine
pathology decreased to 112.52± 9.54 U/L, that was
1.2 times lower than those in patients with DM.
According to the research results, before
prosthodontic treatment, salivary cortisol levels of
patients with DM were 2.4 times higher as com-
pared to patients without somatic pathology. This
indicated impaired regulation in DM, as glucocor-
ticoids affect, directly or indirectly, all the phys-
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iological and biochemical processes in the body.
Before prosthodontic treatment of complete tooth
loss with CRLD, salivary glucose level of patients
with DM was 0.44 ± 0.05 mol/l exceeding the nor-
mal range and that of patients without comorbid-
ity (0.23 ± 0.02 mol/l) by 1.5 and 1.9 times, re-
spectively, p < 0.01. According to the results ob-
tained, the increase in salivary stress factors of all
the patients was found to be the most significant in
adaptation phase I, the phase of reflex stimulation.
However, in patients with DM, salivary cortisol con-
centration increased drastically by 1.4 times as com-
pared to the indicator obtained before prosthodontic
treatment (5.61± 0.83 ng/ml vs. 4.02± 0.65 ng/ml,
p < 0.01), while in the group of patients without
endocrine pathology, cortisol levels increased by
1.2 times. On the 3rd day of adaptation to CRLD,
salivary glucose level of patients with DM increased
by 1.3 times, while in patients without endocrine
pathology, it increased by 1.1 times; in patients of
Group I, sAA levels increased by 1.2 times, while in
patients of Group II, sAA concentration increased
by 1.05 times. Adaptation phase II, the phase of
conditioned reflex inhibition, was characterized by
a more moderate increase in salivary concentration
of cortisol, glucose and ptyalin (AA) in all the pa-
tients; however, in patients with DM, the indicators
of all the salivary stress factors were significantly
higher as compared to patients without endocrine
pathology.
Adaptation phase III was characterized by the
extinction of conditioned reflex stimuli. In patients
with DM, a further increase in salivary concentra-
tion of cortisol, glucose and AA was observed, that
indicated prolonged stress response to CRLD, while
in patients without endocrine pathology, only slight
increase in salivary cortisol levels and decrease in
glucose concentration and amylolytic activity were
observed, indicating better adaptation mechanisms
in this group of patients.
3. Discussion
The study of salivary stress factors in diabetic pa-
tients with CRLD revealed that before prosthodon-
tic treatment, their salivary cortisol levels were 2.4
times higher as compared to patients without so-
matic pathology. This indicated impaired regula-
tion in DM, since glucocorticoids affect, directly
or indirectly, all the physiological and biochemical
processes in the body. According to the research re-
sults, the most significant increase in salivary stress
factors in all the patients was observed in adaptation
phase I, the phase of reflex stimulation. However, in
diabetic patients, salivary cortisol levels increased
drastically by 1.4 times as compared to the indicator
before prosthodontic treatment (5.61 ± 0.83 ng/ml
vs. 4.02± 0.65 ng/ml, p< 0.01), while in the group
of patients without endocrine pathology, salivary
cortisol concentration increased by 1.2 times. On
the 3rd day of adaptation to CRLD, salivary concen-
tration of glucose in diabetic patients increased by
1.3 times, while in patients without DM, it increased
by 1.1 times; in patients of Group I, sAA concen-
tration increased by 1.2 times, while in patients
of Group II, sAA levels increased by 1.05 times.
Adaptation phase II, the phase of conditioned reflex
inhibition, was characterized by a more moderate
increase in salivary levels of cortisol, glucose and
ptyalin (AA) in all the patients; however, in diabetic
patients, the indicators of all the salivary stress fac-
tors were significantly higher as compared to pa-
tients without endocrine pathology. In adaptation
phase III, in patients with DM, a further increase
in salivary concentration of cortisol, glucose and
AA was observed, that indicated prolonged stress
response to CRLD.
The results of this research are consistent with
the findings obtained by Riabushko N.O. et al.,
Tsuber V.Yu. and Van Steregen A [10, 11, 12].
4. Conclusions
Summarizing the data obtained, we can assert that
saliva is among the first to respond to stress. In
patients with DM, changes in saliva composition
indicate a significant reduction in the adaptation
mechanisms. Removable denture, as an irritative
factor, causes the activation of the sympathetic ner-
vous system, stimulates a significant increase in
salivary stress factors that, in patients with DM,
complicates and significantly prolongs the period of
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adaptation and reduces the time of effective CRLD
use.
Prospects of Further Researches
We plan to conduct a questionnaire survey of pa-
tients with DM who use CRLD to clarify compli-
cations arising in prosthodontic treatment with re-
movable dentures. The results of interactive ques-
tionnaire survey will be used in the development of
preventive and therapeutic strategy to improve the
efficacy of prosthodontic treatment with CRLD and
prevention of potential complications in patients
with DM.
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